SABSW icon

SAB Biotherapeutics, Inc. Warrant
SABSW

Overview Fund Activity

21 hedge funds and large institutions have $3.86M invested in SAB Biotherapeutics, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
9
Closed
10
Calls
$2.34M
Puts
–
Net Calls
+$2.34M
Net Calls Change
+$2.28M

Top Buyers

1
SCM
Shaolin Capital Management
Florida
$1.51M
2
LP
LMR Partners
United Kingdom
$127K
3
FBCM
Fort Baker Capital Management
California
$66K
4
Morgan Stanley
Morgan Stanley
New York
$56K
5
CCM
Context Capital Management
California
$38K

Top Sellers

1
RCM
Radcliffe Capital Management
Pennsylvania
$632K
2
OCAM
Owl Creek Asset Management
New York
$0
3
CH
CVI Holdings
Delaware
$104K
4
KC
Kepos Capital
New York
$0
5
PAMP
Polar Asset Management Partners
Ontario, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
UOC
26
UBS O'Connor
Illinois
– -$116K -124,996 Closed
GCL
27
Glazer Capital LLC
New York
– -$108K -117,505 Closed
BCM
28
Basso Capital Management
Connecticut
– -$80K -87,475 Closed
AA
29
AQR Arbitrage
Connecticut
– -$45K -50,000 Closed
PC
30
Periscope Capital
Ontario, Canada
– -$28K -30,647 Closed
EAM
31
Exos Asset Management
New York
– -$25K -27,500 Closed
1
2